Perceive Biotherapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Perceive Biotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Long-Term Follow Up of VOY-101 Non-nAMD Extension Study (NCT07660640) | Perceive Biotherapeutics, Inc. | 2026-03-03 |
| Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration (NCT06087458) | Perceive Biotherapeutics, Inc. | 2023-06-21 |
| Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration (NCT05380492) | Perceive Biotherapeutics, Inc. | 2022-11-17 |
Track Perceive Biotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.